TransAct Technologies Incorporated Forecast, price target & analysts
TransAct Technologies Incorporated Target price 2025 - Analyst rating & recommendation
TransAct Technologies Incorporated Classifications & Recommendation:
TransAct Technologies Incorporated Price Target
| Target Price | $6.38 |
| Price | $3.57 |
| Potential |
78.57%
register free of charge
|
| Number of Estimates | 4 |
|
4 Analysts have issued a price target TransAct Technologies Incorporated 2026 .
The average TransAct Technologies Incorporated target price is $6.38.
This is
78.57%
register free of charge
$7.88
120.59%
register free of charge
$5.05
41.46%
register free of charge
|
|
| A rating was issued by 8 analysts: 7 Analysts recommend TransAct Technologies Incorporated to buy, 1 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the TransAct Technologies Incorporated stock has an average upside potential 2026 of
78.57%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 43.38 | 49.81 |
| 40.27% | 14.82% | |
| EBITDA Margin | -5.97% | -1.50% |
| 160.23% | 74.88% | |
| Net Margin | -22.73% | -5.16% |
| 447.54% | 77.30% |
4 Analysts have issued a sales forecast TransAct Technologies Incorporated 2025 . The average TransAct Technologies Incorporated sales estimate is
This results in the following potential growth metrics:
Revenue Estimates
| 2024 | $43.4m | 40.27% |
|---|---|---|
| 2025 |
$49.8m
14.82%
Unlock
|
|
4 Analysts have issued an TransAct Technologies Incorporated EBITDA forecast 2025. The average TransAct Technologies Incorporated EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
EBITDA Estimates
| 2024 | $-2.6m | 135.97% |
|---|---|---|
| 2025 |
$-746k
71.19%
Unlock
|
|
EBITDA Margin
| 2024 | -5.97% | 160.23% |
|---|---|---|
| 2025 |
-1.50%
74.88%
Unlock
|
|
4 TransAct Technologies Incorporated Analysts have issued a net profit forecast 2025. The average TransAct Technologies Incorporated net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Net Profit Estimates
| 2024 | $-9.9m | 307.58% |
|---|---|---|
| 2025 |
$-2.6m
73.94%
Unlock
|
|
Net Margin
| 2024 | -22.73% | 447.54% |
|---|---|---|
| 2025 |
-5.16%
77.30%
Unlock
|
|
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share $ | -0.99 | -0.26 |
| 310.64% | 73.74% | |
| P/E | negative | |
| EV/Sales | 0.50 |
4 Analysts have issued a TransAct Technologies Incorporated forecast for earnings per share. The average TransAct Technologies Incorporated EPS is
This results in the following potential growth metrics and future valuations:
Earnings Per Share
| 2024 | $-0.99 | 310.64% |
|---|---|---|
| 2025 |
$-0.26
73.74%
Unlock
|
|
P/E ratio
| Current | -4.06 | 106.74% |
|---|---|---|
| 2025 |
-14.00
245.10%
Unlock
|
|
Based on analysts' sales estimates for 2025, the TransAct Technologies Incorporated stock is valued at an EV/Sales of
This results in the following potential growth metrics and future valuations:
EV/Sales
| Current | 0.54 | 20.00% |
|---|---|---|
| 2025 |
0.50
7.76%
Unlock
|
|
P/S ratio
| Current | 0.79 | 33.10% |
|---|---|---|
| 2025 |
0.72
8.15%
Unlock
|
|
TransAct Technologies Incorporated...
Current TransAct Technologies Incorporated Upgrades & Downgrades
| Analyst | Rating | Action | Date |
|---|---|---|---|
| Roth MKM |
Locked
➜
Locked
|
Locked | May 14 2025 |
| Analyst Rating | Date |
|---|---|
|
Locked
Roth MKM:
Locked
➜
Locked
|
May 14 2025 |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
